Antimicrobial Peptide Delivery Systems as Promising Tools Against Resistant Bacterial Infections

Area of Science:

• Biotechnology
• Pharmacology
• Infectious Diseases

Background:

• Antimicrobial resistance (AMR) is a major global health threat, causing millions of deaths annually and projected to increase significantly.
• Existing antibiotics are becoming less effective, necessitating the urgent development of novel antimicrobial agents.
• Antimicrobial peptides (AMPs) offer broad-spectrum antibacterial activity but face clinical limitations like instability and toxicity.

Purpose of the Study:

• To provide an overview of the clinical applications of AMPs against resistant bacterial infections.
• To explore nanoformulation as a strategy to enhance AMP efficacy and overcome their limitations.
• To evaluate metal, polymeric, and lipid-based AMP delivery systems for treating resistant infections.

Main Methods:

• Literature review and analysis of existing research on AMPs and nanoformulation.
• Evaluation of different nano-delivery systems (metal, polymeric, lipid) for AMPs.
• Assessment of the potential of these nanoformulated AMPs in combating resistant bacterial infections.

Main Results:

• Nanoformulation significantly improves AMP stability, selectivity, bioavailability, and therapeutic window.
• Metal, polymeric, and lipid-based nano-delivery systems show promise in enhancing AMPs' antibacterial efficacy.
• These nanoformulated AMPs represent a viable strategy to address the limitations of conventional AMPs.

Conclusions:

• Nanoformulated AMPs offer a promising therapeutic approach to combatting the growing threat of antibiotic-resistant bacterial infections.
• The evaluated metal, polymeric, and lipid delivery systems provide potential solutions to enhance AMP clinical utility.
• Further research and development in AMP nanoformulation are crucial for advancing novel antimicrobial therapies.